This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2021-2023.
Company Filing History:
Years Active: 2021-2023
Title: Emma R Harding: Innovator in Antibody Engineering
Introduction
Emma R Harding is a prominent inventor based in Stevenage, GB. She has made significant contributions to the field of antibody engineering, focusing on improving bioavailability for subcutaneous administration in humans. With a total of 2 patents to her name, her work is paving the way for advancements in medical treatments.
Latest Patents
Emma's latest patents revolve around antibody variants. The present invention relates to methods of selecting, screening, engineering, making, and modifying antibodies that have improved bioavailability upon subcutaneous administration to a human. These innovations are crucial for enhancing the effectiveness of therapeutic antibodies in clinical settings.
Career Highlights
Emma R Harding is associated with GlaxoSmithKline Intellectual Property Development Limited, where she applies her expertise in antibody engineering. Her work is instrumental in developing new methods that can significantly impact patient care and treatment outcomes.
Collaborations
Emma collaborates with notable colleagues, including Valeriu Damian and Austin Keith Doyle. Their combined efforts contribute to the innovative research and development in the field of biotechnology.
Conclusion
Emma R Harding is a key figure in the advancement of antibody engineering, with her patents reflecting her commitment to improving medical treatments. Her contributions are vital for the future of therapeutic applications in healthcare.